CS Investment Funds 2 - Credit Suisse (Lux) Digital Health Equity Fund A EURRegistreer u om de ratings zichtbaar te maken |
Hoe heeft dit fonds gepresteerd? | 29/02/2024 |
Ontwikkeling van EUR 1000 (EUR) | Uitgebreide Grafiek |
Fonds | 71,2 | -13,7 | -32,1 | 4,9 | 4,7 | |
+/-Cat | 59,9 | -30,4 | -22,3 | 5,7 | -0,2 | |
+/-Idx | - | -39,7 | -32,3 | 5,1 | -2,2 | |
Categorie: Aandelen Sector Farmacie & Gezondheid | ||||||
Benchmark: Morningstar Gbl Health TME ... |
Kerngegevens | ||
Koers 26/03/2024 | EUR 117,70 | |
Rendement 1 Dag | 0,72% | |
Morningstar Categorie™ | Aandelen Sector Farmacie & Gezondheid | |
ISIN | LU1877633989 | |
Grootte Fonds (Mil) 27/03/2024 | USD 1476,80 | |
Grootte Fondsklasse (Mil) 27/03/2024 | EUR 12,83 | |
Aankoopkosten (Max) | 5,00% | |
Lopende Kosten Factor 12/03/2024 | 1,90% | |
Gesloten voor nieuwe beleggers | nee |
Beleggingsdoelstelling: CS Investment Funds 2 - Credit Suisse (Lux) Digital Health Equity Fund A EUR |
The objective of the Subfund is to achieve the highest possible return in US dollars (Reference Currency), while taking due account of the principle of risk diversification, the security of the capital invested, and the liquidity of the assets. This Subfund aims to outperform the return of the MSCI World ESG Leaders (NR) benchmark. The Subfund is actively managed. The benchmark is used as a reference point for portfolio construction and as a basis for setting risk constraints, and/or for Performance Fee measurement purposes. The majority of the Subfund’s equity securities will not necessarily be components of or have weightings derived from the benchmark. The Investment Manager will use its discretion to significantly deviate the weighting of certain components of the benchmark and to significantly invest in companies or sectors not included in the benchmark in order to take advantage of specific investment opportunities. |
Returns | ||||||||||||||||
|
Management | ||
Naam manager Aanvangsdatum | ||
Thomas Amrein 14/12/2017 | ||
Oprichtingsdatum 14/09/2018 |
Advertentie |
Benchmark | |
Benchmark van het fonds | Benchmark Morningstar |
MSCI World ESG Leaders NR USD | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Waar belegt het fonds in? CS Investment Funds 2 - Credit Suisse (Lux) Digital Health Equity Fund A EUR | 29/02/2024 |
|
|
Top 5 posities | Sector | % |
Veeva Systems Inc Class A | Gezondheidszorg | 4,05 |
Redcare Pharmacy NV | Gezondheidszorg | 3,98 |
Zealand Pharma A/S | Gezondheidszorg | 3,90 |
Natera Inc | Gezondheidszorg | 3,89 |
10x Genomics Inc Ordinary Shares... | Gezondheidszorg | 3,68 |
Toename Afname Nieuw t.o.v. vorige portefeuille | ||
CS Investment Funds 2 - Credit Suisse (Lux) Digital Health Equity Fund A EUR |